BACKGROUND AND PURPOSE: The Tinetti Performance-Oriented Mobility Assessment (POMA) is commonly used to measure balance ability in older adults. The purpose of this study was to determine the test-retest reliability and minimal detectable change (MDC) of the POMA and explore its cross-sectional and longitudinal construct validity for use in people early after stroke. METHODS: Participants were recruited if they had a first documented stroke and were receiving physical therapy during inpatient rehabilitation. The POMA, gait speed, and motor Functional Independence Measure (FIM) scores were collected at admission and at discharge from inpatient rehabilitation. A second trial of the POMA was conducted 1 day after the first trial for reliability analysis. Correlations (Spearman ρ) between raw scores of admission and discharge outcome measures, as well as change in scores between admission and discharge, were used to explore the construct validity of the POMA. RESULTS: Fifty-five people, with average age of 75 ± 11 years, who had experienced first documented stroke participated in the study and began inpatient physical therapy at a mean of 8 ± 5 days poststroke. Test-retest reliability intraclass correlation coefficient (ICC2,1) was 0.84 and MDC was 6 points. The POMA scores were moderately correlated to motor FIM and gait speed scores at admission (rs = 0.55 and 0.70) and discharge (rs = 0.55 and 0.82.) Change scores of all 3 measures had a fair correlation (rs = 0.28-0.51). DISCUSSION AND CONCLUSIONS: Test-retest reliability and MDC of the POMA in people with stroke is similar to previous research in older adult long-term care residents. Results support cross-sectional and longitudinal construct validity of the POMA in persons early after stroke and demonstrate validity and reliability to measure balance ability in this population.Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A39) for more insights from the authors.
BACKGROUND AND PURPOSE: The Tinetti Performance-Oriented Mobility Assessment (POMA) is commonly used to measure balance ability in older adults. The purpose of this study was to determine the test-retest reliability and minimal detectable change (MDC) of the POMA and explore its cross-sectional and longitudinal construct validity for use in people early after stroke. METHODS:Participants were recruited if they had a first documented stroke and were receiving physical therapy during inpatient rehabilitation. The POMA, gait speed, and motor Functional Independence Measure (FIM) scores were collected at admission and at discharge from inpatient rehabilitation. A second trial of the POMA was conducted 1 day after the first trial for reliability analysis. Correlations (Spearman ρ) between raw scores of admission and discharge outcome measures, as well as change in scores between admission and discharge, were used to explore the construct validity of the POMA. RESULTS: Fifty-five people, with average age of 75 ± 11 years, who had experienced first documented stroke participated in the study and began inpatient physical therapy at a mean of 8 ± 5 days poststroke. Test-retest reliability intraclass correlation coefficient (ICC2,1) was 0.84 and MDC was 6 points. The POMA scores were moderately correlated to motor FIM and gait speed scores at admission (rs = 0.55 and 0.70) and discharge (rs = 0.55 and 0.82.) Change scores of all 3 measures had a fair correlation (rs = 0.28-0.51). DISCUSSION AND CONCLUSIONS: Test-retest reliability and MDC of the POMA in people with stroke is similar to previous research in older adult long-term care residents. Results support cross-sectional and longitudinal construct validity of the POMA in persons early after stroke and demonstrate validity and reliability to measure balance ability in this population.Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A39) for more insights from the authors.
Authors: Kimberley-Dale Ng; Sina Mehdizadeh; Andrea Iaboni; Avril Mansfield; Alastair Flint; Babak Taati Journal: IEEE J Transl Eng Health Med Date: 2020-05-28 Impact factor: 3.316
Authors: Tamaya Van Criekinge; Wim Saeys; Ann Hallemans; Luc Vereeck; Willem De Hertogh; Patricia Van de Walle; Nathalie Vaes; Christophe Lafosse; Steven Truijen Journal: Trials Date: 2017-06-02 Impact factor: 2.279
Authors: G Puyuelo-Quintana; R Cano-de-la-Cuerda; A Plaza-Flores; E Garces-Castellote; D Sanz-Merodio; A Goñi-Arana; J Marín-Ojea; E García-Armada Journal: J Neuroeng Rehabil Date: 2020-05-06 Impact factor: 4.262